サマリー

市場分析と洞察中国の医薬品発酵工学市場
2022年の中国医薬品発酵工学市場規模は172,067百万人民元で、2029年末には437,002百万人民元に達すると予測され、2023-2029年の年平均成長率は14.03%である。

医薬品発酵工学の中国主要プレーヤーには、Joincare Pharmaceutical Group、North China Pharma、Sichuan Kelun Pharmaceutical、CSPC Pharmaceutical Group、Harbin Pharmaceutical Group、United Laboratories International Holdings、Shanghai Fosun Pharmaceutical、Tonghua Dongbao Pharmaceutical、Changchun GeneScience Pharmaceuticalなどが含まれる。売上高では、中国の大手3社が2022年に医薬品発酵工学の12.06％の市場シェアを占めている。

中国の医薬品発酵工学の範囲と市場規模
医薬品発酵工学市場は、プレーヤー別、タイプ別、用途別に区分される。中国医薬用発酵エンジニアリング市場のプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになります。セグメント別分析では、2018年から2029年までの収益と予測について、タイプ別と用途別に焦点を当てています。

中国医薬品発酵工学市場で事業を展開している主要企業は以下の通りです：
Changchun GeneScience Pharmaceutical社
3SBio Inc
上海佛山製薬
四川ケルン製薬
上海シンデック製薬
CSPC医薬グループ
ユナイテッド・ラボラトリーズ・インターナショナル・ホールディングス
東方製薬
ジョインケア製薬グループ
華北製薬
安徽安科生物技術有限公司
ガン・アンド・リー製薬
山東克興生物製品
ハルビン製薬グループ

タイプ別セグメント
モノクローナル抗体
抗生物質
インスリン
ヒト成長ホルモン
医薬品アミノ酸
その他
用途別セグメント
病院
クリニック
その他

ページTOPに戻る

目次

1 Report Overview 1
1.1 Study Scope 1
1.2 Market Analysis by Type 1
1.2.1 China Fermentation Engineering for Pharmaceutical Drugs Market Size Growth Rate by Type: 2018 VS 2023 VS 2029 1
1.2.2 Monoclonal Antibodies 3
1.2.3 Antibiotic 4
1.2.4 Insulin 5
1.2.5 Human Growth Hormone 6
1.2.6 Pharmaceutical Amino Acids 7
1.2.7 Other 8
1.3 Market by Application 9
1.3.1 China Fermentation Engineering for Pharmaceutical Drugs Market Size by Application: 2018 VS 2023 VS 2029 9
1.3.2 Hospital 11
1.3.3 Clinic 12
1.4 China Fermentation Engineering for Pharmaceutical Drugs Market Perspective (2018-2029) 13
2 Competition Landscape 15
2.1 China Fermentation Engineering for Pharmaceutical Drugs Revenue by Company 15
2.1.1 China Fermentation Engineering for Pharmaceutical Drugs Revenue by Players (2018-2023) 15
2.1.2 China Fermentation Engineering for Pharmaceutical Drugs Revenue Market Share by Players (2018-2023) 16
2.2 China Fermentation Engineering for Pharmaceutical Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 18
2.3 Players Covered: Ranking by Fermentation Engineering for Pharmaceutical Drugs Revenue 19
2.4 China Fermentation Engineering for Pharmaceutical Drugs Market Concentration Ratio 20
2.4.1 China Fermentation Engineering for Pharmaceutical Drugs Market Concentration 20
2.4.2 China Top 5 Companies by Fermentation Engineering for Pharmaceutical Drugs Revenue in 2022 20
2.5 China Key Players of Fermentation Engineering for Pharmaceutical Drugs, Headquarters and Area Served 20
2.6 China Key Players of Fermentation Engineering for Pharmaceutical Drugs, Product and Application 21
2.7 Mergers & Acquisitions, Expansion Plans 22
3 Key Players Profiles 24
3.1 Changchun GeneScience Pharmaceutical 24
3.1.1 Changchun GeneScience Pharmaceutical Company Details 24
3.1.2 Changchun GeneScience Pharmaceutical Business Overview 24
3.1.3 Changchun GeneScience Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Introduction 25
3.1.4 Changchun GeneScience Pharmaceutical in China Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2018-2023) 25
3.2 3SBio Inc 26
3.2.1 3SBio Inc Company Details 26
3.2.2 3SBio Inc Business Overview 27
3.2.3 3SBio Inc Fermentation Engineering for Pharmaceutical Drugs Introduction 27
3.2.4 3SBio Inc in China Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2018-2023) 28
3.3 Shanghai Fosun Pharmaceutical 29
3.3.1 Shanghai Fosun Pharmaceutical Company Details 29
3.3.2 Shanghai Fosun Pharmaceutical Business Overview 30
3.3.3 Shanghai Fosun Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Introduction 30
3.3.4 Shanghai Fosun Pharmaceutical in China Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2018-2023) 31
3.4 Sichuan Kelun Pharmaceutical 32
3.4.1 Sichuan Kelun Pharmaceutical Company Details 32
3.4.2 Sichuan Kelun Pharmaceutical Business Overview 33
3.4.3 Sichuan Kelun Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Introduction 34
3.4.4 Sichuan Kelun Pharmaceutical in China Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2018-2023) 34
3.5 Shanghai Shyndec Pharmaceutical 35
3.5.1 Shanghai Shyndec Pharmaceutical Company Details 35
3.5.2 Shanghai Shyndec Pharmaceutical Business Overview 35
3.5.3 Shanghai Shyndec Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Introduction 35
3.5.4 Shanghai Shyndec Pharmaceutical in China Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2018-2023) 36
3.6 CSPC Pharmaceutical Group 37
3.6.1 CSPC Pharmaceutical Group Company Details 37
3.6.2 CSPC Pharmaceutical Group Business Overview 37
3.6.3 CSPC Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Introduction 38
3.6.4 CSPC Pharmaceutical Group in China Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2018-2023) 38
3.7 United Laboratories International Holdings 39
3.7.1 United Laboratories International Holdings Company Details 39
3.7.2 United Laboratories International Holdings Business Overview 40
3.7.3 United Laboratories International Holdings Fermentation Engineering for Pharmaceutical Drugs Introduction 40
3.7.4 United Laboratories International Holdings in China Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2018-2023) 41
3.8 Tonghua Dongbao Pharmaceutical 42
3.8.1 Tonghua Dongbao Pharmaceutical Company Details 42
3.8.2 Tonghua Dongbao Pharmaceutical Business Overview 43
3.8.3 Tonghua Dongbao Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Introduction 43
3.8.4 Tonghua Dongbao Pharmaceutical in China Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2018-2023) 45
3.9 Joincare Pharmaceutical Group 45
3.9.1 Joincare Pharmaceutical Group Company Details 45
3.9.2 Joincare Pharmaceutical Group Business Overview 46
3.9.3 Joincare Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Introduction 46
3.9.4 Joincare Pharmaceutical Group in China Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2018-2023) 48
3.10 North China Pharma 49
3.10.1 North China Pharma Company Details 49
3.10.2 North China Pharma Business Overview 50
3.10.3 North China Pharma Fermentation Engineering for Pharmaceutical Drugs Introduction 50
3.10.4 North China Pharma in China Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2018-2023) 50
3.11 Anhui Anke Biotechnology 51
3.11.1 Anhui Anke Biotechnology Company Details 51
3.11.2 Anhui Anke Biotechnology Business Overview 52
3.11.3 Anhui Anke Biotechnology Fermentation Engineering for Pharmaceutical Drugs Introduction 52
3.11.4 Anhui Anke Biotechnology in China Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2018-2023) 53
3.12 Gan and Lee Pharmaceuticals 53
3.12.1 Gan and Lee Pharmaceuticals Company Details 53
3.12.2 Gan and Lee Pharmaceuticals Business Overview 54
3.12.3 Gan and Lee Pharmaceuticals Fermentation Engineering for Pharmaceutical Drugs Introduction 54
3.12.4 Gan and Lee Pharmaceuticals in China Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2018-2023) 55
3.13 Shandong Kexing Bioproducts 56
3.13.1 Shandong Kexing Bioproducts Company Details 56
3.13.2 Shandong Kexing Bioproducts Business Overview 57
3.13.3 Shandong Kexing Bioproducts Fermentation Engineering for Pharmaceutical Drugs Introduction 57
3.13.4 Shandong Kexing Bioproducts in China Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2018-2023) 58
3.14 Harbin Pharmaceutical Group 59
3.14.1 Harbin Pharmaceutical Group Company Details 59
3.14.2 Harbin Pharmaceutical Group Business Overview 60
3.14.3 Harbin Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Introduction 60
3.14.4 Harbin Pharmaceutical Group in China Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2018-2023) 60
4 Fermentation Engineering for Pharmaceutical Drugs Breakdown Data by Type 62
4.1 China Fermentation Engineering for Pharmaceutical Drugs Historic Market Size by Type (2018-2023) 62
4.2 China Fermentation Engineering for Pharmaceutical Drugs Forecasted Market Size by Type (2024-2029) 62
4.3 China Fermentation Engineering for Pharmaceutical Drugs Market Size Market Share by Type (2018-2029) 63
4.4 Worldwide Biopharmaceutical Manufacturing Capacity Analysis 63
5 Fermentation Engineering for Pharmaceutical Drugs Breakdown Data by Application 67
5.1 China Fermentation Engineering for Pharmaceutical Drugs Historic Market Size by Application (2018-2023) 67
5.2 China Fermentation Engineering for Pharmaceutical Drugs Forecasted Market Size by Application (2024-2029) 67
5.3 China Fermentation Engineering for Pharmaceutical Drugs Revenue Market Share by Application (2018-2029) 68
6 Industry Development Environment Analysis 69
6.1 Fermentation Engineering for Pharmaceutical Drugs Industry Trends 69
6.2 Fermentation Engineering for Pharmaceutical Drugs Market Drivers 70
6.3 Fermentation Engineering for Pharmaceutical Drugs Market Challenges 74
6.4 Fermentation Engineering for Pharmaceutical Drugs Market Restraints 75
7 Industry Chain Analysis 77
7.1 Fermentation Engineering for Pharmaceutical Drugs Industry Chain Analysis 77
7.2 Fermentation Engineering for Pharmaceutical Drugs Key Raw Materials 77
7.2.1 Key Raw Materials 77
7.2.2 Raw Materials Key Suppliers 78
7.3 Fermentation Engineering for Pharmaceutical Drugs Industry Procurement Model 79
7.4 Fermentation Engineering for Pharmaceutical Drugs Production Model 79
7.5 Fermentation Engineering for Pharmaceutical Drugs Sales Model 81
8 Analyst's Viewpoints/Conclusions 82
9 Appendix 84
9.1 Research Methodology 84
9.1.1 Methodology/Research Approach 84
9.1.2 Data Source 87
9.2 Author Details 89
9.3 Disclaimer 90